Who are Exonics Therapeutics's investors?

Exonics Therapeutics's investors include Artis Ventures, Ridgeback Capital, The Column Group.

How much funding has Exonics Therapeutics raised?

Exonics Therapeutics has disclosed $22M raised across 1 round.

Exonics Therapeutics is headquartered in Watertown, US.

Watertown, US · Founded 2016 · 3 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the Exonics Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Developing CRISPR/Cas9 gene editing for neuromuscular diseases; acquired by Vertex in June 2019 for up to $1B.

John RippleExecutive

Jesper GromadaChief Scientific Officer2018–2019Investor at Third Rock Ventures

H. James MageeNamed on SEC filing

Roger PerlmutterNamed on SEC filing

JeenJoo KangBoard directorVenture Partner at The Column Group

David GoeddelBoard directorPartner Emeritus at The Column Group

Form D private placements

$22M disclosed across 1 round · 2017

▶$22MraisedNov 2018 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Exonics Therapeutics do?: Developing CRISPR/Cas9 gene editing for neuromuscular diseases; acquired by Vertex in June 2019 for up to $1B.
Who are Exonics Therapeutics's investors?: Exonics Therapeutics's investors include Artis Ventures, Ridgeback Capital, The Column Group.
How much funding has Exonics Therapeutics raised?: Exonics Therapeutics has disclosed $22M raised across 1 round.
Where is Exonics Therapeutics headquartered?: Exonics Therapeutics is headquartered in Watertown, US.